Viridian Therapeutic (VRDN) PT Lowered to $30 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Lisa Walter lowered the price target on Viridian Therapeutic (NASDAQ: VRDN) to $30.00 (from $42.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
